Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review

Author:

Canan Chelsea1,Polinski Jennifer M2,Alexander G Caleb134,Kowal Mary K2,Brennan Troyen A2,Shrank William H5

Affiliation:

1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

2. CVS Health, Woonsocket, RI, USA

3. Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, USA

4. Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA

5. University of Pittsburgh Medical Center Health Plan, Pittsburgh, PA, USA

Abstract

Abstract Objective Improved methods to identify nonmedical opioid use can help direct health care resources to individuals who need them. Automated algorithms that use large databases of electronic health care claims or records for surveillance are a potential means to achieve this goal. In this systematic review, we reviewed the utility, attempts at validation, and application of such algorithms to detect nonmedical opioid use. Materials and Methods We searched PubMed and Embase for articles describing automatable algorithms that used electronic health care claims or records to identify patients or prescribers with likely nonmedical opioid use. We assessed algorithm development, validation, and performance characteristics and the settings where they were applied. Study variability precluded a meta-analysis. Results Of 15 included algorithms, 10 targeted patients, 2 targeted providers, 2 targeted both, and 1 identified medications with high abuse potential. Most patient-focused algorithms (67%) used prescription drug claims and/or medical claims, with diagnosis codes of substance abuse and/or dependence as the reference standard. Eleven algorithms were developed via regression modeling. Four used natural language processing, data mining, audit analysis, or factor analysis. Discussion Automated algorithms can facilitate population-level surveillance. However, there is no true gold standard for determining nonmedical opioid use. Users must recognize the implications of identifying false positives and, conversely, false negatives. Few algorithms have been applied in real-world settings. Conclusion Automated algorithms may facilitate identification of patients and/or providers most likely to need more intensive screening and/or intervention for nonmedical opioid use. Additional implementation research in real-world settings would clarify their utility.

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

Reference26 articles.

1. Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014;Rudd;Morbid Mortal Week Rep.,2016

2. Food and Drug Administration. FDA Announces Safety Labeling Changes and Postmarket Study Requirements for Extended-release and Long-acting Opioid Analgesics. 2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367726.htm. Accessed February 1, 2017.

3. Prescription Drug Monitoring Program Center for Technical Assistance and Training. Prescription Drug Monitoring Frequently Asked Questions (FAQ). 2015. http://www.pdmpassist.org/content/prescription-drug-monitoring-frequently-asked-questions-faq. Accessed April 30, 2016.

4. Validation of a screener and opioid assessment measure for patients with chronic pain;Butler;Pain.,2004

5. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R);Butler;J Pain.,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3